Initiation and maintenance of the pluripotent epiblast in pre-implantation human development is independent of NODAL signaling

Early
Published

November 18, 2024

Abstract
The human blastocyst contains the pluripotent epiblast from which human embryonic stem cells (hESCs) can be derived. ACTIVIN/NODAL signaling maintains expression of the transcription factor NANOG and in vitro propagation of hESCs. It is unknown whether this reflects a functional requirement for epiblast development in human embryos. Here, we characterized NODAL signaling activity during pre-implantation human development. We showed that NANOG is an early molecular marker restricted to the nascent human pluripotent epiblast and was initiated prior to the onset of NODAL signaling. We further demonstrated that expression of pluripotency-associated transcription factors NANOG, SOX2, OCT4, and KLF17 were maintained in the epiblast in the absence of NODAL signaling activity. Genome-wide transcriptional analysis showed that NODAL signaling inhibition did not decrease NANOG transcription or impact the wider pluripotency-associated gene regulatory network. These data suggest differences in the signaling requirements regulating pluripotency in the pre-implantation human epiblast compared with existing hESC culture.

Files

json

DOI:10.1016/j.devcel.2024.10.020

Protocols

Protocol for immunofluorescence detection and quantification of phosphorylated SMAD proteins in human blastocysts

DOI:10.1016/j.xpro.2025.103849

Code

Segmentation and image analysis pipeline for the investigation of lineage marker expression in early human development

DOI:10.25418/crick.19383428.v1

Datasets

NODAL signalling does not initiate or maintain the pluripotent epiblast in pre-implantation human development

BioStudies:S-BIAD1398

Network